Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.51 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.51 |
| ▸ | HPGD | P15428 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | TRAP1 | Q12931 | 1/20 | 0.44 |
| ▸ | OPRM1 | P35372 | 3/20 | 0.43 |
| ▸ | HTR3A | P46098 | 3/20 | 0.42 |
| ▸ | CACNA1G | O43497 | 2/20 | 0.42 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | PKM | P14618 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17242550 | 0.91 | KDM4E (0.55) | ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1 | |
| SCHEMBL17241581 | 0.85 | KDM4E (0.71) | ALDH1A1KDM4ESMN1; SMN2MAPK1KMT2A | |
| SCHEMBL17241606 | 0.83 | KDM4E (0.55) | ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A | |
| SCHEMBL17242523 | 0.81 | KDM4E (0.56) | ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A | |
| SCHEMBL17242675 | 0.81 | KDM4E (0.67) | ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A | |
| SCHEMBL17242600 | 0.80 | PKM (0.49) | ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1 | |
| SCHEMBL17242631 | 0.80 | KDM4E (0.45) | ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A | |
| SCHEMBL17241749 | 0.79 | MAPK1 (0.47) | ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1 | |
| SCHEMBL17242581 | 0.79 | TRAP1 (0.46) | ALDH1A1KDM4ESMN1; SMN2HPGDMAPK1 | |
| SCHEMBL17242632 | 0.78 | DDR1 (0.64) | ALDH1A1KDM4ESMN1; SMN2HPGDKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170137387-A1 | PHARMACOLOGICALLY ACTIVE QUINAZOLINEDIONE DERIVATIVES | ORION CORPORATION (FI) | 2017-05-18 | — | — | US | disclosed |
| EP-3140301-A1 | PHARMACOLOGICALLY ACTIVE QUINAZOLINEDIONE DERIVATIVES | Orion Corporation (FI) | 2017-03-15 | — | — | EP | disclosed |
| WO-2015169999-A1 | PHARMACOLOGICALLY ACTIVE QUINAZOLINEDIONE DERIVATIVES | ORION CORPORATION (FI) | 2015-11-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170137387-A1 | PHARMACOLOGICALLY ACTIVE QUINAZOLINEDIONE DERIVATIVES | GABRB1, GABRB3, GABRB2 | ALDH1A1 819/4885KDM4E 1998/4885SMN1; SMN2 2872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.